Private Securities Litigation Reform Act

RETA INVESTOR DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Reata Pharmaceuticals Inc.

Thursday, November 26, 2020 - 4:21pm

The lawsuit filed in the United States District Court for the Eastern District of Texas alleges violations of the Securities Exchange Act of 1934.

Key Points: 
  • The lawsuit filed in the United States District Court for the Eastern District of Texas alleges violations of the Securities Exchange Act of 1934.
  • The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding the Companys business, operations and prospects.
  • If you wish to serve as lead plaintiff, you must move the Court no later than December 14, 2020.
  • A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

SHAREHOLDER ALERT: Lowey Dannenberg, P.C. Reminds Investors of a Pending Securities Class Action Lawsuit against Evolus Inc. and Encourages Investors with Losses in Excess of $50,000 to Contact the Firm

Wednesday, November 25, 2020 - 11:28am

The class action alleges violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the "Exchange Act"), 15 U.S.C.

Key Points: 
  • The class action alleges violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the "Exchange Act"), 15 U.S.C.
  • 78j(b) and 78t(a) and Rule 10b-5 promulgated thereunder by the SEC, 17 C.F.R.
  • The class action is titled In re Evolus Securities Litigation, No.
  • Over decades of zealous advocacy, Lowey has developed a profound knowledge of securities and antitrust class action litigation.

BMRN Final Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds BioMarin Pharmaceutical Inc. Investors With Losses Exceeding $100K of Class Action and Lead Plaintiff Deadline: November 24, 2020

Tuesday, November 24, 2020 - 3:00pm

Such investors are encouraged to join this case by visiting the firms site: www.bgandg.com/bmrn .

Key Points: 
  • Such investors are encouraged to join this case by visiting the firms site: www.bgandg.com/bmrn .
  • This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.
  • If you suffered a loss in BioMarin you have until November 24, 2020 to request that the Court appoint you as lead plaintiff.
  • Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Arena Pharmaceuticals to Present at the Evercore ISI HealthCONx Conference on December 1

Tuesday, November 24, 2020 - 1:30pm

A live webcast of the presentation will be posted under the investor relations section of Arena's website at www.arenapharm.com .

Key Points: 
  • A live webcast of the presentation will be posted under the investor relations section of Arena's website at www.arenapharm.com .
  • ARENA Pharmaceuticals is a team with a singular purpose deliver our important medicines to patients.
  • For such statements, Arena claims the protection of the Private Securities Litigation Reform Act of 1995.
  • Arena disclaims any intent or obligation to update these forward-looking statements, other than as may be required under applicable law.

HeadHunter Group PLC Signs Agreement to Acquire LLC Zarplata.ru

Tuesday, November 24, 2020 - 9:05am

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.

Key Points: 
  • This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.
  • These forward-looking statements are based on managements current expectations.
  • Actual results may differ materially from the results predicted or implied by such statements, and our reported results should not be considered as an indication of future performance.
  • Accordingly, you should not rely upon forward-looking statements as predictions of future events.

LEAD PLAINTIFF DEADLINE: Johnson Fistel, LLP Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Saturday, November 21, 2020 - 6:06pm

The Private Securities Litigation Reform Act of 1995 permits any investor who purchased common stock during the Class Period to seek appointment as lead plaintiff.

Key Points: 
  • The Private Securities Litigation Reform Act of 1995 permits any investor who purchased common stock during the Class Period to seek appointment as lead plaintiff.
  • A lead plaintiff acts on behalf of all other class members in directing the litigation.
  • An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
  • If you wish to serve as lead plaintiff, you must move the Court no later than the dates listed below.

RETA INVESTOR DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Reata Pharmaceuticals Inc.

Thursday, November 19, 2020 - 8:26pm

The lawsuit filed in the United States District Court for the Eastern District of Texas alleges violations of the Securities Exchange Act of 1934.

Key Points: 
  • The lawsuit filed in the United States District Court for the Eastern District of Texas alleges violations of the Securities Exchange Act of 1934.
  • The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding the Companys business, operations and prospects.
  • If you wish to serve as lead plaintiff, you must move the Court no later than December 14, 2020.
  • A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

GOCO Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Notifies GoHealth, Inc. Investors of Class Action and Lead Plaintiff Deadline: November 20, 2020

Wednesday, November 18, 2020 - 4:00pm

Such investors are encouraged to join this case by visiting the firms site: www.bgandg.com/goco .

Key Points: 
  • Such investors are encouraged to join this case by visiting the firms site: www.bgandg.com/goco .
  • This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1933.
  • If you suffered a loss in GoHealth you have until November 20, 2020 to request that the Court appoint you as lead plaintiff.
  • Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Psychedelic-focused Media, E-commerce and Event Company DELIC Holdings to Begin Trading on the Canadian Securities Exchange Under Ticker Symbol “DELC”

Wednesday, November 18, 2020 - 1:30pm

This news release does not constitute an offer to sell, or a solicitation of an offer to buy, any securities in the United States.

Key Points: 
  • This news release does not constitute an offer to sell, or a solicitation of an offer to buy, any securities in the United States.
  • This press release contains certain forward-looking information within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute forward-looking statements within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995.
  • In addition, in connection with the forward-looking information and forward-looking statements contained in this press release, DELIC has made certain assumptions.
  • All subsequent written and oral forward- looking information and statements attributable to DELIC or persons acting on its behalf is expressly qualified in its entirety by this notice.

Stride, Inc. Expands Ability to Meet Demands of IT Skills Gap with Acquisition of Tech Elevator

Tuesday, November 17, 2020 - 10:15pm

Stride executives will host a Virtual Investor Day, November 18, 2020.

Key Points: 
  • Stride executives will host a Virtual Investor Day, November 18, 2020.
  • Presentations, including a question and answer session, will begin promptly at 10:30 am ET and conclude by approximately 2:30 pm ET.
  • A replay of the Investor Day will also be available on the company's website.
  • This press release contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.